Concord Drugs Ltd

Concord Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Concord Drugs Ltd

₹ 52.0 -2.00%
14 Aug - close price
concorddrugs.in BSE: 538965
About

Incorporated in 1995, Concord Drugs Ltd manufactures licensed drugs based on
approved formulations

Key Points

Product Portfolio:[1]
a) Pharmaceutical Ready to fill Pellets
b) Multiple Unit Pellet System (MUPS)
c) Tissue Bio Adhesive
d) Injectables (Small Volume Parenterals)
e) Oral Solid Dosages (Tablets & Capsules)
f) Liquid Orals (Syrups & Suspensions)
g) Dry Syrup (Powder)

Website BSE
  • Market Cap ₹ 52.0 Cr.
  • Current Price ₹ 52.0
  • High / Low ₹ 67.0 / 26.1
  • Stock P/E 121
  • Book Value ₹ 34.1
  • Dividend Yield 0.00 %
  • ROCE 5.30 %
  • ROE 1.00 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company's working capital requirements have reduced from 152 days to 116 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 1.86% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
12.54 13.72 13.53 12.31 8.98 7.53 12.78 15.64 11.69 12.37 10.80 10.39 13.61
11.56 12.53 12.08 11.34 7.52 5.91 12.15 15.29 10.86 11.49 9.40 9.34 12.59
Operating Profit 0.98 1.19 1.45 0.97 1.46 1.62 0.63 0.35 0.83 0.88 1.40 1.05 1.02
OPM % 7.81% 8.67% 10.72% 7.88% 16.26% 21.51% 4.93% 2.24% 7.10% 7.11% 12.96% 10.11% 7.49%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.34 0.42 0.45 0.50 0.44 0.43 0.50 0.50 0.45 0.47 0.50 0.61 0.49
Depreciation 0.39 0.53 0.38 0.33 0.38 0.39 0.39 0.39 0.34 0.34 0.37 0.38 0.37
Profit before tax 0.25 0.24 0.62 0.14 0.64 0.80 -0.26 -0.54 0.04 0.07 0.53 0.06 0.16
Tax % 28.00% 25.00% 25.81% -21.43% 23.44% 30.00% -3.85% -38.89% 50.00% 42.86% 58.49% 33.33% 25.00%
0.19 0.18 0.45 0.16 0.49 0.56 -0.24 -0.34 0.03 0.04 0.23 0.04 0.12
EPS in Rs 0.22 0.21 0.51 0.17 0.53 0.60 -0.24 -0.34 0.03 0.04 0.23 0.04 0.12
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
58.96 52.08 44.92 45.25 47.17
53.37 47.51 40.88 41.10 42.82
Operating Profit 5.59 4.57 4.04 4.15 4.35
OPM % 9.48% 8.77% 8.99% 9.17% 9.22%
0.10 0.01 0.01 0.00 0.00
Interest 1.68 1.71 1.87 2.03 2.07
Depreciation 1.76 1.63 1.56 1.43 1.46
Profit before tax 2.25 1.24 0.62 0.69 0.82
Tax % 28.89% 20.97% 25.81% 50.72%
1.59 0.99 0.47 0.34 0.43
EPS in Rs 1.82 1.06 0.47 0.34 0.43
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -8%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -40%
TTM: 4200%
Stock Price CAGR
10 Years: -2%
5 Years: 30%
3 Years: 25%
1 Year: 60%
Return on Equity
10 Years: %
5 Years: %
3 Years: 2%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8.74 9.32 10.00 10.00
Reserves 19.62 22.38 23.82 24.11
16.43 16.96 17.52 17.19
11.66 9.57 7.47 13.84
Total Liabilities 56.45 58.23 58.81 65.14
13.97 12.92 11.68 12.21
CWIP 0.55 0.92 1.63 2.00
Investments 0.00 0.89 0.84 0.80
41.93 43.50 44.66 50.13
Total Assets 56.45 58.23 58.81 65.14

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.77 1.66 0.79 3.72
-2.44 -2.27 -1.01 -2.32
1.68 0.62 0.28 -1.43
Net Cash Flow 0.01 0.02 0.07 -0.02

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 141.52 110.80 161.13 109.70
Inventory Days 151.64 178.58 251.53 261.81
Days Payable 62.25 46.92 37.75 78.95
Cash Conversion Cycle 230.90 242.47 374.91 292.56
Working Capital Days 112.48 152.43 187.70 115.75
ROCE % 6.31% 4.98% 5.30%

Shareholding Pattern

Numbers in percentages

5 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
49.00% 49.00% 52.13% 52.13% 52.13% 55.41% 55.41% 55.41% 54.39% 54.39% 54.39% 54.39%
51.00% 51.00% 47.87% 47.87% 47.87% 44.59% 44.60% 44.60% 45.61% 45.61% 45.61% 45.61%
No. of Shareholders 3,1883,3213,2043,1983,9574,0324,7344,7555,0735,0735,2525,189

Documents

Announcements

Annual reports

Credit ratings